Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-08 | CATALYST PHARMACEUTICALS, INC. | Tierney David S
(Director) |
S | Common stock, par value $0.001 per share | D | 25000 | $15.68 - $15.68 | $392,000 |
| 2024-04-08 | CATALYST PHARMACEUTICALS, INC. | Tierney David S
(Director) |
M | Common stock, par value $0.001 per share | A | 25000 | $4.01 - $4.01 | $100,250 |
| 2024-03-27 | CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian
(Chief Compliance/Legal Officer) |
S | Common stock, par value $0.001 per share | D | 25000 | $16.44 - $16.44 | $411,000 |
| 2024-01-02 | CATALYST PHARMACEUTICALS, INC. | Tierney David S
(Director) |
M | Common Stock, Par Value $0.001 per share | A | 10000 | $1.13 - $1.13 | $11,299 |
| 2023-12-15 | CATALYST PHARMACEUTICALS, INC. | Harper Molly
(Director) |
S | Common stock, par value $0.001 per share | D | 14000 | $14.37 - $14.43 | $201,420 |
| 2023-12-15 | CATALYST PHARMACEUTICALS, INC. | Harper Molly
(Director) |
M | Common stock, par value $0.001 per share | A | 10000 | $5.78 - $5.78 | $57,800 |
| 2023-12-12 | CATALYST PHARMACEUTICALS, INC. | Tierney David S
(Director) |
S | Common stock, par value $0.001 per share | D | 50000 | $13.32 - $13.32 | $666,250 |
| 2023-12-12 | CATALYST PHARMACEUTICALS, INC. | Tierney David S
(Director) |
M | Common stock, par value $0.001 per share | A | 50000 | $1.13 - $1.13 | $56,499 |
| 2023-12-11 | CATALYST PHARMACEUTICALS, INC. | Miller Steve
(Chief Op. & Scientific Officer) |
M | Common stock, par value $0.001 per share | A | 150000 | $1.13 - $1.13 | $169,499 |
| 2023-12-08 | CATALYST PHARMACEUTICALS, INC. | GRANDE ALICIA
(VP, Treasurer and CFO) |
S | Common Stock, par value $0.001 per share | D | 100000 | $13.74 - $14.30 | $1,396,780 |
| 2023-12-08 | CATALYST PHARMACEUTICALS, INC. | GRANDE ALICIA
(VP, Treasurer and CFO) |
M | Common stock, par value $0.001 per share | A | 100000 | $1.13 - $1.13 | $112,999 |
| 2023-12-05 | CATALYST PHARMACEUTICALS, INC. | Miller Steve
(Chief Op. & Scientific Officer) |
S | Common stock, par value $0.001 per share | D | 40000 | $14.24 - $14.24 | $569,600 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |